Springer Nature
Browse
40164_2019_141_MOESM1_ESM.docx (89.31 kB)

MOESM1 of Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

Download (89.31 kB)
journal contribution
posted on 2019-08-07, 04:22 authored by Alexandra Albertsson-Lindblad, Catja Freiburghaus, Mats Jerkeman, Sara Ek
Additional file 1. Supplementary tables and figures & Methodology and Material.

History

Usage metrics

    Experimental Hematology & Oncology

    Categories

    Keywords

    Mantle cell lymphomaAntibody-dependent cell deathIbrutinibLenalidomideCD20 antibody

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC